Business
MultiCorp International, Inc. Announces the Hiring of Healthcare Executive to Become New Chief Executive Officer
MultiCorp International, Inc. Announces the Hiring of Healthcare Executive to Become New Chief Executive Officer.
About this update from Multicorp International, Inc.
[{"type":"text","content":"\n \n \n MultiCorp International, Inc. Announces the Hiring of Healthcare Executive to Become New Chief Executive Officer\n \n \nMultiCorp International, Inc. Announces the Hiring of Healthcare Executive to Become New Chief Executive Officer\n\nMr. David Gustafson to Take Over as CEO of Company\n\n \n SUN VALLEY, CA--(Marketwired - Feb 11, 2016) - MultiCorp International, Inc, (OTC PINK: MCIC) announced today that the company has hired David Gustafson as the new CEO of the company. \n The company released the following statement, \"MultiCorp International, Inc. is excited to announce that Mr. David Gustafson has taken over the helm of Chief Executive Officer of the company on an interim basis. The current CEO, Mr. Paul D. Lisenby, is taking a leave of absence due to medical reasons. There is no timetable for his return. In the meantime, we welcome Mr. Gustafson aboard as our CEO to spearhead the efforts of the company in the further development of the patented migraine medicine. Mr. Gustafson's 35 years of broad based, comprehensive, professional experience in the health care industry ranging from the operation of hospitals to medical groups, to integrated health delivery systems will benefit the company in developing and managing the 4-Arm Study the FDA is requiring for the migraine medicine, move the drug into further clinical trials, and to look for additional opportunities in the healthcare field for the company that can be capitalized upon to bring in additional revenue and profits. The Board of Directors also stated that they may possibly change the name of the company to further reflect the company's direction in the healthcare sector. The BOD also stated there will be no changes to the share structure of the company at this time.\"\n About MultiCorp International, Inc. \n MultiCorp International, Inc is committed itself to the further development of the patented migraine medicine the company owns a significant percentage of. The company has received information from the U.S. Food and Drug Administration that provides the company with a clear path to further the development of the drug to bring to market. The company is currently looking to partner with a pharmaceutical company that can assist the company in bringing the migraine medicine to market. For further information please contact them at info@multicorpinternationa...